Evidence map›Paper›PMID 26067761›Full record

ArticleAmerican journal of respiratory and critical care medicine2015

Pulmonary Microvascular Blood Flow in Mild Chronic Obstructive Pulmonary Disease and Emphysema. The MESA COPD Study.

Katja Hueper, Jens Vogel-Claussen, Megha A Parikh, John H M Austin, David A Bluemke, James Carr, Jiwoong Choi, Thomas A Goldstein, Antoinette S Gomes, Eric A Hoffman and 14 more

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed, 1 pooled it
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 1 synthesis or guideline pooled it, 174 citations in OpenAlex.

  1. The effects of lung volume reduction treatment on diffusing capacity and gas exchange.European respiratory review : an official journal of the European Respiratory Society · 2020
    Pooled it
  2. Trial
  3. Article
  4. Imaging Markers of Chronic Obstructive Pulmonary Disease on Computed Tomography of the Lungs: a Narrative Review.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Functional Pulmonary Imaging.Journal of magnetic resonance imaging : JMRI · 2025
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 13 institutions in 5 countries.

Katja Hueper1 Department of Radiology and.
Jens Vogel-Claussen1 Department of Radiology and.
Megha A Parikh3 Department of Medicine.
John H M Austin4 Department of Radiology, and.
David A Bluemke5 Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, Maryland.
James Carr6 Department of Radiology and.
Jiwoong Choi7 Department of Radiology.
Thomas A Goldstein9 Department of Biomedical Engineering, Stanford University, Stanford, California.
Antoinette S Gomes10 Department of Radiology and.
Eric A Hoffman7 Department of Radiology.
Steven M Kawut13 Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Joao Lima1 Department of Radiology and.
Erin D Michos14 Department of Medicine, Johns Hopkins University, Baltimore, Maryland.
Wendy S Post14 Department of Medicine, Johns Hopkins University, Baltimore, Maryland.
Ming Jack Po15 Department of Biomedical Engineering and.
Martin R Prince4 Department of Radiology, and.
Kiang Liu16 Department of Biostatistics, Northwestern University, Chicago, Illinois.
Dan Rabinowitz17 Department of Statistics, Columbia University, New York, New York; and.
Jan Skrok1 Department of Radiology and.
Ben M Smith3 Department of Medicine.
Karol Watson18 Department of Medicine, University of California at Los Angeles, Los Angeles, California.
Youbing Yin19 VIDA Diagnostics, Coralville, Iowa.
Alan M Zambeli-Ljepovic15 Department of Biomedical Engineering and.
R Graham Barr3 Department of Medicine.
Johns Hopkins University · USPediatrics and Genetics · USInstitute of Biophysics and Biomedical Engineering · BGUniversity of California, Los Angeles · USUniversity of Iowa · USColumbia University · USColumbia University Irving Medical Center · USMedizinische Hochschule Hannover · DENational Institutes of Health Clinical Center · USNorthwestern University · USStanford University · USUniversity of Pennsylvania · USVida Diagnostics (United States) · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024156 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2006 to 2011
$53.0M
Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Brandi Janssen · 1990 to 2026
$40.5M
Vector Core-Core 2P30DK054759 · NIDDK · UNIVERSITY OF IOWA · PI Alejandro Antonio Pezzulo · 1998 to 2026
$30.5M
Pulmonary microvascular perfusion in the Multi-Ethnic Study of AtherosclerosisR01HL077612 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI R Graham BARR · 2004 to 2026
$18.8M
Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary Disease (COPD)R01HL093081 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI R Graham BARR · 2008 to 2026
$17.2M
Molecular Biomedical Imaging Laboratory (NIBIB)ZIAEB000072 · NIBIB · NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING · PI BLUEMKE, DAVID · 2010 to 2017
$5.0M
Multi-center Structural & Functional Quantitative CT Pulmonary PhenotypingR01HL112986 · NHLBI · UNIVERSITY OF IOWA · PI HOFFMAN, ERIC ALFRED · 2012 to 2016
$4.6M
Fish Oil Intake, Biomarkers and Change in Lung FunctionR01HL075476 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BARR, R GRAHAM · 2004 to 2008
$2.8M
Mentored Patient-Oriented Research in Pulmonary Arterial HypertensionK24HL103844 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI KAWUT, STEVEN M · 2011 to 2020
$1.6M
Adjunctive Use of Apyrase to Fibrinolytic TherapyR44HL095169 · NHLBI · APT THERAPEUTICS, INC. · PI CHEN, RIDONG · 2012 to 2013
$1.3M
SUBCLINICAL CARDIOVASCULAR DISEASE STUDYN01HC095166 · HC · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI TRACY, RUSSELL P · 1999 to 2001
$758k
SUBCLINICAL CARDIOVASCULAR DISEASE STUDY-FIELD CENTERN01HC095162 · HC · JOHNS HOPKINS UNIVERSITY · PI SZKLO, MOYSES A · 1999 to 2000
$694k
NCRR NIH HHS UL1 RR024156NHLBI NIH HHS K24 HL103844NHLBI NIH HHS N01 HC095169NHLBI NIH HHS N01-HC95159NHLBI NIH HHS N01-HC95160NHLBI NIH HHS N01-HC95161NHLBI NIH HHS N01-HC95162NHLBI NIH HHS N01-HC95163NHLBI NIH HHS N01-HC95164NHLBI NIH HHS N01-HC95165NHLBI NIH HHS N01-HC95166NHLBI NIH HHS N01-HC95167NHLBI NIH HHS N01-HC95168NHLBI NIH HHS N01-HC95169NHLBI NIH HHS R01 HL075476NHLBI NIH HHS R01-HL075476NHLBI NIH HHS R01 HL077612NHLBI NIH HHS R01-HL077612NHLBI NIH HHS R01 HL093081NHLBI NIH HHS R01-HL093081NHLBI NIH HHS R01 HL112986NHLBI NIH HHS R01-HL-112986NIDDK NIH HHS P30 DK054759NIEHS NIH HHS P30 ES005605
6 · The paper itself

Abstract

rationaleSmoking-related microvascular loss causes end-organ damage in the kidneys, heart, and brain. Basic research suggests a similar process in the lungs, but no large studies have assessed pulmonary microvascular blood flow (PMBF) in early chronic lung disease.

objectivesTo investigate whether PMBF is reduced in mild as well as more severe chronic obstructive pulmonary disease (COPD) and emphysema.

methodsPMBF was measured using gadolinium-enhanced magnetic resonance imaging (MRI) among smokers with COPD and control subjects age 50 to 79 years without clinical cardiovascular disease. COPD severity was defined by standard criteria. Emphysema on computed tomography (CT) was defined by the percentage of lung regions below -950 Hounsfield units (-950 HU) and by radiologists using a standard protocol. We adjusted for potential confounders, including smoking, oxygenation, and left ventricular cardiac output. MEASUREMENTS AND MAIN

resultsAmong 144 participants, PMBF was reduced by 30% in mild COPD, by 29% in moderate COPD, and by 52% in severe COPD (all P < 0.01 vs. control subjects). PMBF was reduced with greater percentage emphysema-950HU and radiologist-defined emphysema, particularly panlobular and centrilobular emphysema (all P ≤ 0.01). Registration of MRI and CT images revealed that PMBF was reduced in mild COPD in both nonemphysematous and emphysematous lung regions. Associations for PMBF were independent of measures of small airways disease on CT and gas trapping largely because emphysema and small airways disease occurred in different smokers.

conclusionsPMBF was reduced in mild COPD, including in regions of lung without frank emphysema, and may represent a distinct pathological process from small airways disease. PMBF may provide an imaging biomarker for therapeutic strategies targeting the pulmonary microvasculature.

Indexed as

Pulmonary CirculationAgedCase-Control StudiesCohort StudiesFemaleGadoliniumHumansLungMagnetic Resonance ImagingMaleMicrovesselsMiddle AgedPerfusion ImagingProspective StudiesPulmonary Disease, Chronic ObstructivePulmonary EmphysemaGadoliniumchronic obstructive pulmonary disease (COPD)gadolinium-enhanced MRIlung emphysemapulmonary microvascular blood flow (PMBF)small airway disease

Identifiers

PMID26067761
PMCPMC4595687
OpenAlexW2104157879

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.